Your Source forOncology and Cancer Information

 

Program
Title
Time
Price
MA-0224M

Diagnosis & Treatment of Urologic Cancers

120 min
$289.00

Seth Lerner, MD; Ron Bukowski, MD; Chris Logothetis, MD; Richard Williams, MD; Michael Sorodsky, MD

This program deals with testes cancer; bladder cancer- BCG, alternatives to BCG therapy, and metastatic bladder cancer; and renal cell cancer - single agent therapies including IL-2 high dose and alpha interferon, combination therapy of IL-2 low dose and alpha interferon, and surgery to treat renal cell - does it improve survivability.
MA-0309M

Cancer Update: Diagnosis & Treatment of Prostate Cancer
120 min.
$289.00

Joseph Oesterling, MD; Arthur Porter, MD; Anthony Zeitman, MD; Jerry Ritchie, MD; David Paulson, MD; Michael K. Brawer, MD

Featured topics of this program include the use of PSA in diagnosis and staging of prostate cancer, transrectal ultrasound, improving the results of radical treatment for locally advanced prostate cancer, radical prostatectomy, maximum androgen deprivation therapy, and radionuclide therapy for metastatic prostate cancer.

MA-0411M

Breast Cancer: Advances in Screening, Diagnosis & Treatment
180 min.
$329.00

Laszlo Tabar, MD; Linda Warren, MD; Richard Bird, MD; Jeffery Weinreb, MD; Kevin Fox, MD; Barbara Fowble, MD; Michael Osborne, MD; John Hainsworth, MD

Topics included in this program are: The effectiveness of mammographic screening; the diagnostic workup: mammography, sonography, MRI; and therapeutic options: radiotherapy, chemotherapy, and surgury.
MA-0428M

AIDS Research Forum: HIV & AIDS Related Lymphoma/Anti-Retroviral Therapy 
30 min
$189.00

(No Description Available)
MA-0922M

Advances in the Treatment of Non-small Cell Lung Cancer
120 min.
$289.00

Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD

Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC
MC-0918M

Advances in the Treatment of Non-small Cell Lung Cancer

 150 min.
$309.00

(No Description Available)
MD-0506M

Advances in the Treatment of Non-small Cell Lung Cancer

 90 min.
$249.00

Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD

Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC
MA-1107N

Cancer Pain Management: Identifying Appropriate Nursing Roles & Interventions      
120 min.
$289.00

Leta Truett, RN, MN, CCRN; Deborah M. Thorpe, PhD, RN, CS; Mary Cunningham, RN, MS; Talulah Ruger, RN, BSN

This program features physicians and doctors discussing various appropriate nursing rules and interventions in pain management. The major areas of discussion are as follows: acute or post-operative pain management - current techniques and therapies, barriers to effective management; chronic non-malignant pain management or behavioral/cognitive pain management- classifications of chronic non-malignant pain characteristics, data collection, and treatment, cancer pain management - dosing regimens; nursing assessment for acute, chronic non-malignant or cancer pain - current therapies and techniques, point controlled analgesia (PCA), epidural analgesia.

MA-1130M

Disease Management: Prostate Cancer    
120 min.
  $289.00

Paul Shelhamer, MD; Charles Metzger, MD; Anthony Zeitman, MD; Mark Solloway, MD

A prestigious panel of physicians discussing the management of prostate cancer with specific topics including: anti-androgens and the treatment of metastatic prostate cancer; management of prostate disease in a single specialty managed care environment; neoadjuvant therapy and radiotherapy.

MB-0221M

Cancer Update: Diagnosis & Treatment of Leukemia 
120 min.
$289.00

Richard Champlin, MD; Bruce D. Cheson, MD; Michael Bishop, MD; Frederick R. Appelbuam, MD; Frank J. Giles, MD; Charles A. Schiffer, MD

For physicians who have interest in or occasion to diagnose or treat cancer patients. Presentations will feature discussions about various leukemias and treatments of the disease.
MB-0301M

Bladder Cancer: Improved Treatment Options
120 min.
$289.00

William U. Shipley, MD(Moderator); Derek Raghavan, MD, PhD; Harry W. Herr, MD; Mark S. Soloway, MD; M'Liss A. Hudson, MD; Niall M. Heney, MD; Paul F. Schellhammer, MD; Donald S. Kaufman, MD

Topics include superficial and invisible bladder cancer, diagnosis of patients presenting with either hematuria and dysuria, endoscopic and intravesical chemotherapeutic methods, systematic chemotherapy for advanced bladder cancer.
MB-0308M

Disease Management: Breast Cancer  
90 min.
$249.00

V. Craig Jordan, PhD, D.Sc; Gabriel Hortobagyi, MD, FACP; Monica Morrow, MD

Long Term Tamoxifen Treatment for Breast Cancer, High Dose Combination Chemotherapy, and Issues in the Local Therapy of Breast Cancer.


This healthcare portal website has been created as a source of objective and credible health and medical information for healthcare professionals and consumers and does not endorse any specific product, service or organization. MEDIVISION does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professional.
COPYRIGHT © MEDIVISION, 2011